Withdrawal of Authorization for Device TB-2 and Stock Disposal

The authorization request for the product Device TB-2 as a biocidal product (Reg. 528/2012) has been officially rejected. Therefore, the product, previously authorized as Medical-Surgical Device No. 19035, is no longer approved for sale.

The deadlines for stock disposal and usage of the aforementioned product are as follows:

• January 2, 2024 – Final date for the commercialization of existing stock on the market
• June 30, 2024 – Final date for product usage

Colkim remains available for any further information and/or clarification.